Scott J. Denardo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Scott J. Denardo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Eileen M. Handberg
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL (J.V., E.M.H., C.J.P.).
4 shared publications Annette Champion
Abbott Laboratory, Abbott Park, Illinois
3 shared publicationsCarl J. Pepine
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida
3 shared publications- Carl J. Pepine
University of Florida
3 shared publications Franz H. Messerli
C Division of Cardiology, St Luke’s-Roosevelt Hospital Center and Columbia University College of Medicine and Physicians, New York, NY
3 shared publicationsRhonda M. Cooper-DeHoff
A Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville
3 shared publications
Latest Publications
- 1 August 2010
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (8) , 719-726
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy
- 1 August 2010
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (8) , 719-726
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy
- 1 August 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (4) , 498-503
Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])
- 1 August 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (4) , 498-503
Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])
- 1 January 2010
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 3 (1) , 149-156
Pulse Wave Analysis of the Aortic Pressure Waveform in Severe Left Ventricular Systolic Dysfunction
Background— The effect of moderate left ventricular systolic dysfunction (LVSD) on ventricular/vascular coupling and the aortic pressure waveform (AoPW) has been well described, but the effect of severe LVSD has not. Methods and Results— We used noninvasive, high-fidelity tonometry of the radial artery and a mathematical transfer function to generate the AoPW in 25 treated patients with LVSD (mean LV ejection fraction, 24±8.8%; range, 11% to 40%; 21 patients P P P P P P P P P 2 dyne sec/cm 2 versus 17±10×10 2 dyne sec/cm 2 ; P 2 mm Hg-sec/min versus 23±4.2×10 2 mm Hg sec/min; P P Conclusions— Severe LVSD causes measurable changes in the AoPW. Standardization of AoPW findings in LVSD patients may allow for the clinical use of radial artery pulse wave analysis to noninvasively determine the severity of dysfunction and aid in logical therapy.
- 1 January 2010
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 3 (1) , 149-156
Pulse Wave Analysis of the Aortic Pressure Waveform in Severe Left Ventricular Systolic Dysfunction
Background— The effect of moderate left ventricular systolic dysfunction (LVSD) on ventricular/vascular coupling and the aortic pressure waveform (AoPW) has been well described, but the effect of severe LVSD has not. Methods and Results— We used noninvasive, high-fidelity tonometry of the radial artery and a mathematical transfer function to generate the AoPW in 25 treated patients with LVSD (mean LV ejection fraction, 24±8.8%; range, 11% to 40%; 21 patients P P P P P P P P P 2 dyne sec/cm 2 versus 17±10×10 2 dyne sec/cm 2 ; P 2 mm Hg-sec/min versus 23±4.2×10 2 mm Hg sec/min; P P Conclusions— Severe LVSD causes measurable changes in the AoPW. Standardization of AoPW findings in LVSD patients may allow for the clinical use of radial artery pulse wave analysis to noninvasively determine the severity of dysfunction and aid in logical therapy.
- 1 April 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (4) , 624-630
Characteristics and Outcomes of Revascularized Patients With Hypertension
Our understanding of the growing population of revascularized patients with hypertension is limited. We retrospectively analyzed the International Verapamil SR-Trandolapril Study, which randomized coronary artery disease patients with hypertension to either verapamil SR- or atenolol-based treatment strategies, focusing on characteristics and outcomes of 6166 previously revascularized patients compared with 16 410 nonrevascularized patients. Revascularized patients had a history of coronary artery bypass grafting (45.2%), percutaneous coronary intervention (42.1%), or both (12.8%). Compared with nonrevascularized patients, revascularized patients at baseline demonstrated a higher prevalence of coronary artery disease risk factors and risk conditions ( P P P <0.0001). Associations between adjusted hazard ratio for primary outcome and follow-up blood pressure appeared “J shaped” for both patient groups. Because, as a group, revascularized patients with hypertension had worse outcomes compared with nonrevascularized patients, management of blood pressure to a specific target in future studies could result in improved outcomes.
- 1 April 2009
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (4) , 624-630
Characteristics and Outcomes of Revascularized Patients With Hypertension
Our understanding of the growing population of revascularized patients with hypertension is limited. We retrospectively analyzed the International Verapamil SR-Trandolapril Study, which randomized coronary artery disease patients with hypertension to either verapamil SR- or atenolol-based treatment strategies, focusing on characteristics and outcomes of 6166 previously revascularized patients compared with 16 410 nonrevascularized patients. Revascularized patients had a history of coronary artery bypass grafting (45.2%), percutaneous coronary intervention (42.1%), or both (12.8%). Compared with nonrevascularized patients, revascularized patients at baseline demonstrated a higher prevalence of coronary artery disease risk factors and risk conditions ( P P P <0.0001). Associations between adjusted hazard ratio for primary outcome and follow-up blood pressure appeared “J shaped” for both patient groups. Because, as a group, revascularized patients with hypertension had worse outcomes compared with nonrevascularized patients, management of blood pressure to a specific target in future studies could result in improved outcomes.
- 1 May 2008
- Published by Wolters Kluwer Health in Hypertension
- Vol. 51 (5)
Response to The J-Point Revisited
- 1 May 2008
- Published by Wolters Kluwer Health in Hypertension
- Vol. 51 (5)
Response to The J-Point Revisited
- 1 November 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (9) , 1376-1382
Effectiveness and Safety of Reduced-Dose Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndrome Followed by Antiplatelet Therapy Alone for Percutaneous Coronary Intervention
- 1 November 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (9) , 1376-1382
Effectiveness and Safety of Reduced-Dose Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndrome Followed by Antiplatelet Therapy Alone for Percutaneous Coronary Intervention